Lixte Biotechnology Holdings Company Culture
Lixte Biotechnology Holdings Culture
This score is derived from employee ratings & reviewsTop Rated Culture Dimensions
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterLixte Biotechnology Holdings Company Information
Lixte Biotechnology Holdings Company Overview
Lixte Biotechnology Holdings, a clinical-stage pharmaceutical company, focuses on discovering drugs for more effective cancer treatments.
| Headquarter | 248 Route 25A East Setauket, NY United States of America |
|---|---|
| Website | www.lixte.com |
| Tel | (631) 830-7092 |
| Company Status | Private |
Lixte Biotechnology Holdings Competitors
Lixte Biotechnology Holdings competitors include Biogen, MyoKardia, and Reata Pharmaceuticals. See below how Lixte Biotechnology Holdings compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
Lixte Biotechnology Holdings Careers
Lixte Biotechnology Holdings Jobs
No Recent Jobs found for Lixte Biotechnology Holdings on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
Let Lixte Biotechnology Holdings Know You Want To Work There
Frequently Asked Questions regarding Lixte Biotechnology Holdings
What is Lixte Biotechnology Holdings address?
Lixte Biotechnology Holdings location is at 248 Route 25A
Who are Lixte Biotechnology Holdings competitors?
Lixte Biotechnology Holdings main competitors are Biogen, MyoKardia, Reata Pharmaceuticals
Who is Lixte Biotechnology Holdings leadership?
are part of Lixte Biotechnology Holdings leadership, John Kovach is the CEO
×